Transplant Monitoring Kits Market Size Worth $ 7,723.22 Million By 2032 | CAGR: 4.3%

Transplant Monitoring Kits Market Size Worth $ 7,723.22 Million By 2032 | CAGR: 4.3%

The global transplant monitoring kits market size is expected to reach USD 7,723.22 million by 2032, according to a new study by Polaris Market Research. The report “Transplant Monitoring Kits Market Share, Size, Trends, Industry Analysis Report, By Product Type (Reagents & Consumables, Instruments, and Software & Services); By Technology; By Transplant; By Application; By End User; By Region; Segment Forecast, 2023-2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising awareness regarding transplantation is one of the major factors likely to drive the market rapidly. Several programs and initiatives related to transplant monitoring kits aim to improve patient outcomes and advance the field of transplantation. Transplant Genomics is a company that focuses on developing noninvasive diagnostic tests for transplant monitoring. In addition, under the direction of the Organ Procurement and Transplantation Network, the Membership and Professional Standards Committee (MPSC) evaluates the effectiveness of transplantation programs. Subsequently, such initiatives and programs enhance the demand for monitoring kits worldwide.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The rising prevalence of organ failure and the growing demand for organ transplantation procedures drive the need for effective monitoring tools. As more organ transplants are performed worldwide, the demand for transplant monitoring kits increases. Such a broadening rate of organ transplantation is significantly fueling the market's growth worldwide.

Transplant Monitoring Kits Market Report Highlights

  • Molecular assay technology is anticipated to record the largest market share in the year of 2022 as it offers several advantages in transplant monitoring
  • Reagent and consumables segment held largest share in the global market. These are essential components of transplant monitoring kits as they contain the necessary chemicals, antibodies, probes, and other materials required for performing the molecular assays and tests.
  • Soft tissue segment is expected to expand with fastest CAGR during the forecast period. These procedures are used in a variety of medical specialties, including orthopedic surgery, plastic surgery, and reconstructive surgery.
  • Diagnostic application is accounting largest market share of the global revenue in the fiscal year of 2022. This is linked to the personalized medicine approach, increasing transplantation procedures, and many other factors
  • Independent Reference Laboratories garnered largest market share of the global revenue in 2022. This segment plays an important role in providing specialized testing services and support for transplant monitoring
  • North America held the largest share as of 2022 due to advanced healthcare infrastructure, and increasing research and development
  • The global players include CareDx, Biogenuix Medsystems, Thermo Fisher Scientific, Eurofins Scientific, JETA Molecular, ELITech, QIAGEN, Hologic, Natera, Roche, Bio-Rad Laboratories, Genome Diagnostics, and Sanbio.

Polaris Market Research has segmented the Transplant Monitoring Kits market report based on product type, technology, transplant, application, end user, and region:

Transplant Monitoring Kits, Product Type Outlook (Revenue - USD Million, 2019-2032)

  • Reagents & Consumables
  • Instruments
  • Software & Services

Transplant Monitoring Kits, Technology Outlook (Revenue - USD Million, 2019-2032)

  • Molecular Assay Technologies
  • PCR-Based Molecular Assays
  • Real-time PCR
  • Sequence-specific Primer-PCR
  • Sequence-specific Oligonucleotide-PCR
  • Other PCR-based Molecular Assays
  • Sequencing-based Molecular Assays
  • Sanger Sequencing
  • Next-generation Sequencing
  • Other Sequencing-based Molecular Assays
  • Non-molecular Assay Technologies

Transplant Monitoring Kits, Transplant Type Outlook (Revenue - USD Million, 2019-2032)

  • Solid Organ
  • Stem Cell
  • Soft Tissue

Transplant Monitoring Kits, Application Outlook (Revenue - USD Million, 2019-2032)

  • Diagnostic Applications
  • Pre-transplantation Diagnostics
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
  •  Post-transplantation Diagnostics
  • Research Applications

Transplant Monitoring Kits, End Use Outlook (Revenue - USD Million, 2019-2032)

  • Independent Reference Laboratories
  • Hospitals & Transplant Centres
  • Research Laboratories & Academic Institutes

Transplant Monitoring Kits, Regional Outlook (Revenue - USD Million, 2019-2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Transplant Monitoring Kits Market Report Scope

Report Attributes


Market size value in 2023

USD 5,273.73 million

Revenue forecast in 2032

USD 7,723.22 million


4.3% from 2023 – 2032

Base year


Historical data

2019– 2022

Forecast period

2023– 2032

Quantitative units

Revenue in USD million/billion and CAGR from 2023 to 2032

Segments covered

By Product Type, By Technology, By Transplant, By Application, By End user, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

CareDx Inc., Thermo Fisher Scientific, QIAGEN, Hologic, Eurofins Scientific, JETA Molecular, ELITech Group, Natera Inc., Roche Ltd., Biocare Health Resources Inc., Bio-Rad Laboratories, Biogenuix Medsystems, Genome Diagnostics, and Sanbio.

For Specific Research Requirements

Request for Customized Report